Marie‐Christine Etienne

Prognostic Value of Tumoral Thymidylate Synthase and p53 in Metastatic Colorectal Cancer Patients Receiving Fluorouracil-Based Chemotherapy: Phenotypic and Genotypic Analyses

Marie‐Christine Etienne, M Chazal, Pierre Laurent‐Puig et al. · Journal of Clinical Oncology · 2002 · 176 citations

Methylenetetrahydrofolate reductase gene polymorphisms and response to fluorouracil-based treatment in advanced colorectal cancer patients

Marie‐Christine Etienne, Jean–Louis Formento, M Chazal et al. · Pharmacogenetics · 2004 · 132 citations

Optimal Fluoropyrimidine Efficacy, Fluorouracil-based Treatment, Oncogenic Agent +11

Age-related difference in tamoxifen disposition

F. Peyrade, Marc Frénay, Marie‐Christine Etienne et al. · Clinical Pharmacology & Therapeutics · 1996 · 79 citations

Combination of irinotecan (CPT11) and 5-fluorouracil with an analysis of cellular determinants of drug activity

Valérie Pavillard, Patricia Formento, Philippe Rostagno et al. · Biochemical Pharmacology · 1998 · 69 citations

Drug Activity, Pharmaceutical Science, Drug Analysis +9

Spontaneous or imposed circadian changes in plasma concentrations of 5-fluorouracil coadministered with folinic acid and oxaliplatin: Relationship with mucosal toxicity in patients with cancer

G. Metzger, Claire Massari, Marie‐Christine Etienne et al. · Clinical Pharmacology & Therapeutics · 1994 · 68 citations